Biomed mainz
WebApr 4, 2024 · BERKELEY, Calif. and MAINZ, Germany, April 04, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today that three German-based companies have selected ColoAlert ®, the … WebJan 3, 2024 · Throughout 2024, Mainz Biomed operated in a position of financial strength, having successfully executed a USD 25.8 million public follow-on offering in January, which consisted of 1,725,000 ordinary shares priced at USD 15.00 per share. During the year, to keep pace with product development and commercial growth, the Company made it a …
Biomed mainz
Did you know?
WebApr 10, 2024 · Mainz Biomed B.V. press release ( NASDAQ: MYNZ ): FY GAAP EPS of -$1.86. Revenue of $0.53M (-8.6% Y/Y). Recommended For You Medical Properties … WebApr 10, 2024 · Early identification of Cancer saves lives. To be effective, cancer detection needs to be simple, readily available, and affordable. We develop innovative products … OUR BUSINESS CONCEPT & PIPELINE SAVES LIVES AND HEALTH CARE … COLOALERT TARGET CONDITION COLORECTAL CANCER 37 … Mainz BioMed is developing proprietary genetic testing methods for pancreatic … NEWS English / EnglischGerman / Deutsch All Corporate News All All Corporate … CONTACT CONTACT US To contact us send us a message using the form or … CAREERS CAREERS At Mainz BioMed, every day is about making a difference …
WebApr 10, 2024 · BERKELEY, US – MAINZ, Germany – April 10, 2024 — Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic … Web2 days ago · 11.04.2024 - Die Aktien von Mainz Biomed (WKN: A3C6XX) sind zum Wochenauftakt um -6% abgerutscht und starten am Dienstag aber wieder mit Schwung (+1,3%) in den US-Handel. Anleger hatten sich von ...
WebAug 16, 2024 · About Mainz Biomed N.V. Mainz Biomed develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company’s flagship product is ColoAlert, an accurate, non ... WebApr 10, 2024 · BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the …
WebMar 8, 2024 · Mainz Biomed is supporting this year’s Gastro Update, a series of two 2-day practical training events for healthcare professionals, led by renowned German …
Web21 hours ago · The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mainz Biomed B.V. with a $18.00 average price target, which is a 208.85% upside from current levels. crystal facts for science projectWebApr 10, 2024 · ColoAlert Revenue Increases 130% Year over Year. Year End Cash Balance of $17.1 Million. BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ ... crystal facts scienceWebApr 11, 2024 · What is Mainz Biomed's stock price forecast for 2024? 3 brokerages have issued 1 year target prices for Mainz Biomed's stock. Their MYNZ share price forecasts range from $11.00 to $25.00. On average, they anticipate the company's stock price to reach $17.00 in the next twelve months. dwayne hey hey hey what\\u0027s happeningWebFeb 21, 2024 · Anne Hennecke/Caroline Bergmann. +49 211 529252 20. [email protected]. In the US: Spectrum Science. Melissa Laverty/Valerie Enes. +1 540 272 6465. [email protected]. For investor ... crystal fafardWebApr 10, 2024 · BERKELEY, Calif. and MAINZ, Germany, April 10, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the … crystal fae cosplayWebMar 21, 2024 · BERKELEY, Calif. and MAINZ, Germany, March 21, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed NV (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company ... crystal faeWebFeb 21, 2024 · BERKELEY, Calif. and MAINZ, Germany, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announced today the execution of its option from Uni Targeting Research AS to … crystal fagley